FOQUEST

elvium life sciences🇨🇦 Health Canada

Approval Id: 5525345bef563973
Drug Approval Canada Name: FOQUEST
Product Name: FOQUEST
Status: Marketed
Status Date: 2020-09-03
Original Market Date: 2018-01-11
Din: 02470357
Drug Class: Human
Dosage Form: Capsule (Controlled Release)
Route Of Administration: Oral
Schedule: Schedule G (CDSA III)
Ahfs: 28:20.32
Atc Original: N06BA04 METHYLPHENIDATE
Atc Name: n 06 ba 04
Aig Number: 0107548018
Company Name: elvium life sciences
Company Address: 310, 3381 Steeles Avenue East, Toronto, Ontario, Canada, M2H 3S7

METHYLPHENIDATE HYDROCHLORIDE

100 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

5525345bef563973

Type

Standard